Nathan Bennette

Title: Nathan Bennette: Innovator in Pharmaceutical Formulations

Introduction

Nathan Bennette is a notable inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral dosage forms for medications. With a total of 3 patents to his name, Bennette's work focuses on improving drug delivery systems.

Latest Patents

Bennette's latest patents revolve around formulations of apremilast. These patents describe oral dosage forms that include a core tablet with a drug layer comprising apremilast and hypromellose acetate succinate (HPMCAS) in an amorphous solid dispersion. The core tablet also features a swellable layer made of one or more swellable polymers, along with a coating layer that has at least one drug release orifice. These innovative oral dosage forms are designed to provide once-a-day dosing of apremilast, making them suitable for treating diseases or disorders that can be ameliorated by inhibiting phosphodiesterase subtype IV (PDE4).

Career Highlights

Bennette is currently employed at Amgen Inc., a leading biotechnology company known for its focus on innovative medicines. His work at Amgen has allowed him to contribute to advancements in drug formulations and delivery systems.

Collaborations

Throughout his career, Bennette has collaborated with several talented individuals, including William Brett Caldwell and Christi Hostetler. These collaborations have further enhanced the development of his innovative pharmaceutical formulations.

Conclusion

Nathan Bennette's contributions to the field of pharmaceutical formulations, particularly through his patents on apremilast, highlight his role as an influential inventor. His work continues to impact the way medications are delivered and administered, showcasing the importance of innovation in healthcare.